NasdaqGS - Delayed Quote USD

Inari Medical, Inc. (NARI)

43.75 +1.26 (+2.97%)
At close: May 10 at 4:00 PM EDT
Loading Chart for NARI
DELL
  • Previous Close 42.49
  • Open 42.60
  • Bid 43.70 x 300
  • Ask 43.88 x 100
  • Day's Range 42.17 - 43.78
  • 52 Week Range 36.73 - 71.85
  • Volume 1,006,500
  • Avg. Volume 1,408,450
  • Market Cap (intraday) 2.544B
  • Beta (5Y Monthly) 0.93
  • PE Ratio (TTM) --
  • EPS (TTM) -0.41
  • Earnings Date Jul 31, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 65.82

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

www.inarimedical.com

1,300

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NARI

Performance Overview: NARI

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NARI
32.61%
S&P 500
9.49%

1-Year Return

NARI
37.37%
S&P 500
26.79%

3-Year Return

NARI
54.54%
S&P 500
23.39%

5-Year Return

NARI
--
S&P 500
76.71%

Compare To: NARI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NARI

Valuation Measures

Annual
As of 5/10/2024
  • Market Cap

    2.54B

  • Enterprise Value

    2.47B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.84

  • Price/Book (mrq)

    5.69

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.54%

  • Return on Assets (ttm)

    -0.68%

  • Return on Equity (ttm)

    -5.41%

  • Revenue (ttm)

    520.66M

  • Net Income Avi to Common (ttm)

    -23.62M

  • Diluted EPS (ttm)

    -0.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    101.3M

  • Total Debt/Equity (mrq)

    7.04%

  • Levered Free Cash Flow (ttm)

    46.67M

Research Analysis: NARI

Company Insights: NARI

Research Reports: NARI

People Also Watch